These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34524199)

  • 1. The future of Clostridioides difficile diagnostics.
    Mizusawa M; Carroll KC
    Curr Opin Infect Dis; 2021 Oct; 34(5):483-490. PubMed ID: 34524199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the Association Between Diagnostic Testing Method, Polymerase Chain Reaction Ribotype, and Clinical Outcomes From Clostridioides difficile Infection: One Institution's Experience.
    Menon A; Perry DA; Motyka J; Weiner S; Standke A; Penkevich A; Keidan M; Young VB; Rao K
    Clin Infect Dis; 2021 Nov; 73(9):e2883-e2889. PubMed ID: 32930705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Clostridioides difficile Infection: Diagnosis and Diagnostic Stewardship.
    Schwenk HT; Pollock NR; Vaughan-Malloy AM
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S16-S21. PubMed ID: 34791395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasensitive Clostridioides difficile Toxin Testing for Higher Diagnostic Accuracy.
    Sandlund J; Davies K; Wilcox MH
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32269098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Cycle Threshold, Toxin Concentration, and Clinical Characteristics of Clostridioides difficile Infection in Patients with Discordant Diagnostic Test Results.
    Shah MD; Balada-Llasat JM; Coe K; Reed E; Sandlund J; Pancholi P
    J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32051264
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models.
    Vitucci JC; Pulse M; Tabor-Simecka L; Simecka J
    BMC Microbiol; 2020 Feb; 20(1):27. PubMed ID: 32024477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age.
    Sandora TJ; Williams DN; Daugherty K; Geer C; Cuddemi C; Kociolek LK; Chen X; Xu H; Savage TJ; Banz A; Garey KW; Gonzales-Luna AJ; Kelly CP; Pollock NR
    J Pediatric Infect Dis Soc; 2022 Oct; 11(10):454-458. PubMed ID: 35801632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Evaluation of the mariPOC Test for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxins A/B.
    Savolainen R; Koskinen JM; Mentula S; Koskinen JO; Kaukoranta SS
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31941691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a two step testing algorithm to improve diagnostic accuracy and stewardship of Clostridioides difficile infections.
    Bettger CC; Giancola SE; Cybulski RJ; Okulicz JF; Barsoumian AE
    BMC Res Notes; 2023 Aug; 16(1):172. PubMed ID: 37580824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter Prevalence Study Comparing Molecular and Toxin Assays for Clostridioides difficile Surveillance, Switzerland.
    Widmer AF; Frei R; Kuijper EJ; Wilcox MH; Schindler R; Spaniol V; Goldenberger D; Egli A; Tschudin-Sutter S
    Emerg Infect Dis; 2020 Oct; 26(10):2370-2377. PubMed ID: 32946368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
    Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
    Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Clostridioides difficile toxins detection necessary when the glutamate dehydrogenase enzyme is detected?
    García-Fuentes JF; Torres-Murillo BJ; Aguilar-Orozco G; González É; Mosqueda JL; Macías AE; Álvarez JA
    Gac Med Mex; 2021; 157(1):107-109. PubMed ID: 34125803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in testing and change in testing algorithm associated with decrease in number of nosocomial Clostridioides (Clostridium) difficile infections.
    Cook PP; Nichols S; Coogan M; Opera J; DeHart M
    Am J Infect Control; 2020 Sep; 48(9):1019-1022. PubMed ID: 32044135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasensitive and Quantitative Toxin Measurement Correlates With Baseline Severity, Severe Outcomes, and Recurrence Among Hospitalized Patients With Clostridioides difficile Infection.
    Alonso CD; Kelly CP; Garey KW; Gonzales-Luna AJ; Williams D; Daugherty K; Cuddemi C; Villafuerte-Gálvez J; White NC; Chen X; Xu H; Sprague R; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2022 Jul; 74(12):2142-2149. PubMed ID: 34537841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clostridioides difficile: updated recommendations].
    Barbut F; Eckert C; Lalande V; Le Neindre K; Couturier J
    Rev Prat; 2022 Sep; 72(7):703-709. PubMed ID: 36511953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic trends in Clostridioides difficile isolate ribotypes in United States from 2011 to 2016.
    Snydman DR; McDermott LA; Jenkins SG; Goldstein EJC; Patel R; Forbes BA; Johnson S; Gerding DN; Thorpe CM; Walk ST
    Anaerobe; 2020 Jun; 63():102185. PubMed ID: 32387171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and required improvements in methods to diagnosing
    Mizusawa M; Carroll KC
    Expert Rev Mol Diagn; 2021 Mar; 21(3):311-321. PubMed ID: 33682564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset
    Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.